Details
Stereochemistry | ACHIRAL |
Molecular Formula | C4H7NO |
Molecular Weight | 85.1045 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
O=C1CCCN1
InChI
InChIKey=HNJBEVLQSNELDL-UHFFFAOYSA-N
InChI=1S/C4H7NO/c6-4-2-1-3-5-4/h1-3H2,(H,5,6)
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Efficacy of topical phenol decontamination strategies on severity of acute phenol chemical burns and dermal absorption: in vitro and in vivo studies in pig skin. | 2001 May |
|
Transdermal delivery of physostigmine: effects of enhancers and pressure-sensitive adhesives. | 2002 Aug |
|
Novel potent 5-HT(3) receptor ligands based on the pyrrolidone structure. Effects of the quaternization of the basic nitrogen on the interaction with 5-HT(3) receptor. | 2002 Aug |
|
Palladium-catalyzed aminoallylation of activated olefins with allylic halides and phthalimide. | 2002 Aug 23 |
|
Dermal exposure to aqueous solutions of N-methyl pyrrolidone. | 2002 Aug 5 |
|
A new tin-free source of amidyl radicals. | 2002 Aug 8 |
|
GABA and glutamate in the human brain. | 2002 Dec |
|
Design of inhibitors of scytalone dehydratase: probing interactions with an asparagine carboxamide. | 2002 Dec |
|
Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur. | 2002 Dec 13 |
|
Novel spirocyclic pyrrolidones as P2/P1 mimetics in potent inhibitors of HIV-1 protease. | 2002 Dec 2 |
|
Induction of endothelial cell apoptosis by the antivascular agent 5,6-Dimethylxanthenone-4-acetic acid. | 2002 Jun 17 |
|
Regional differences in expression of VEGF mRNA in rat gastrocnemius following 1 hr exercise or electrical stimulation. | 2002 Jun 19 |
|
Evaluation of CC2 as a decontaminant in various hydrophilic and lipophilic formulations against sulphur mustard. | 2002 Mar |
|
Interaction of influenza A virus M1 matrix protein with caspases. | 2002 May |
|
[Effect of a drug composition containing pyroglutamic acid and pyrrolidone on the cerebral circulation]. | 2002 May-Jun |
|
Enantioselective Michael additions of nitromethane by a catalytic double activation method using chiral lewis Acid and achiral amine catalysts. | 2002 Nov 13 |
|
Nefiracetam induces a long-lasting facilitation of hippocampal postsynaptic responses in mice lacking the NMDA receptor epsilon1 subunit. | 2002 Nov 22 |
|
Influence of storage time and temperature on the stability of indomethacin Pluronic F-127 gels. | 2002 Oct |
|
N-Arylated pyrrolidin-2-ones and morpholin-3-ones as potassium channel openers. | 2002 Oct |
|
Geographic variation of natural products of tropical nudibranch Asteronotus cespitosus. | 2002 Sep |
|
Evaluation of solid dispersions of Clofazimine. | 2002 Sep |
|
Radical carboazidation of alkenes: an efficient tool for the preparation of pyrrolidinone derivatives. | 2002 Sep 16 |
|
Effective inhibition of mannitol crystallization in frozen solutions by sodium chloride. | 2003 Apr |
|
Non-peptide alpha(v)beta(3) antagonists: identification of potent, chain-shortened RGD mimetics that incorporate a central pyrrolidinone constraint. | 2003 Dec 15 |
|
A study of 5-aminolevulinic acid and its methyl ester used in in vitro and in vivo systems of human bladder cancer. | 2003 Feb |
|
[Neuroprotective properties of pyroglutamic acid in combination with pyrrolidone]. | 2003 Jan-Feb |
|
Source reduction for prevention of methylene chloride hazards: cases from four industrial sectors. | 2003 Jul 21 |
|
Pyrrolidinobenzoic acid inhibitors of influenza virus neuraminidase: modifications of essential pyrrolidinone ring substituents. | 2003 Jul 3 |
|
Pyroglutamyl-peptidase I: cloning, sequencing, and characterisation of the recombinant human enzyme. | 2003 Mar |
|
A theoretical study on the complete catalytic cycle of the hetero-Pauson-Khand-type [2+2+1] cycloaddition reaction of ketimines, carbon monoxide and ethylene catalyzed by iron carbonyl complexes. | 2003 Mar 3 |
|
Dichloroketene-chiral olefin-based approach to pyrrolizidines: highly stereocontrolled synthesis of (+)-amphorogynine A. | 2003 May 15 |
|
Pyrrolidonyl and pyridyl alkaloids in Lymantria dispar. | 2003 Nov-Dec |
|
A general treatment of solubility. 1. The QSPR correlation of solvation free energies of single solutes in series of solvents. | 2003 Nov-Dec |
|
Complex formation of protein with different water-soluble synthetic polymers. | 2003 Nov-Dec |
|
Evaluation of critical formulation factors in the development of a rapidly dispersing captopril oral dosage form. | 2003 Oct |
|
Formation of vinylogous compounds in model Maillard reaction systems. | 2003 Oct |
|
Developmental outcome of levetiracetam, its major metabolite in humans, 2-pyrrolidinone N-butyric acid, and its enantiomer (R)-alpha-ethyl-oxo-pyrrolidine acetamide in a mouse model of teratogenicity. | 2003 Oct |
|
Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. | 2003 Oct 1 |
|
Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. | 2003 Oct 2 |
|
Dioxygen-coupled oxidative amination of styrene. | 2003 Oct 29 |
|
Chemical and olfactory characterization of odorous compounds and their precursors in the parotoid gland secretion of the green tree frog, Litoria caerulea. | 2003 Sep |
|
Vibrational and electronic couplings in ultraviolet resonance Raman spectra of cyclic peptides. | 2003 Sep |
|
2-pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs. | 2003 Sep |
|
1-[2-(4-nitrophenoxy)acetyl]pyrrolidin-2-one: an antiamnesic agent. | 2003 Sep |
|
2-pyrrolidinone induces a long-lasting facilitation of hippocampal synaptic transmission by enhancing alpha7 ACh receptor responses via a PKC pathway. | 2003 Sep 10 |
|
Properties and biocompatibility of polypropylene graft copolymer films. | 2004 Feb 15 |
|
CCR5 antagonists as anti-HIV-1 agents. 1. Synthesis and biological evaluation of 5-oxopyrrolidine-3-carboxamide derivatives. | 2004 Jan |
|
Vitrification of bovine oocytes and its application to intergeneric somatic cell nucleus transfer. | 2004 Jan 1 |
|
Discovery of 4-substituted pyrrolidone butanamides as new agents with significant antiepileptic activity. | 2004 Jan 29 |
|
Polyvinylpyrrolidone-drug conjugate: synthesis and release mechanism. | 2004 Jan 8 |
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
36592
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | |||
|
DTXSID8027246
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | |||
|
12025
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | |||
|
2652
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | |||
|
616-45-5
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | |||
|
210-483-1
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | |||
|
4593
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | |||
|
C028537
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | |||
|
2-PYRROLIDONE
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | |||
|
KKL5D39EOL
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | |||
|
1358473
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | RxNorm | ||
|
m9400
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000129573
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | |||
|
SUB39495
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | |||
|
KKL5D39EOL
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY | |||
|
8413
Created by
admin on Fri Dec 15 15:09:18 GMT 2023 , Edited by admin on Fri Dec 15 15:09:18 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD